Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

SC 0806

Next Previous
Drug Profile

SC 0806

Alternative Names: heparin-activated recombinant human fibroblast growth factor 1; rhFGF1 - BioArctic; SC0806

Latest Information Update: 16 Oct 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Swenora Biotech
  • Developer BioArctic
  • Class Fibroblast growth factors; Neuroprotectants
  • Mechanism of Action Fibroblast growth factor replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Spinal cord injuries
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Spinal cord injuries

Most Recent Events

  • 31 May 2025 BioArctic AB completes a phase I/II trial in Spinal cord injuries (In adults) in Sweden and Estonia (Intrathecal) (NCT02490501)
  • 18 Nov 2019 Discontinued - Phase-II for Spinal cord injuries (In adults) in Estonia, Norway, Sweden (Intrathecal)
  • 13 Feb 2019 Phase-II clinical trials in Spinal cord injuries (In adults) in Sweden, Norway and Estonia (Intrathecal)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top